Cargando…
An overview of the efficacy and signaling pathways activated by stem cell-derived extracellular vesicles in diabetic kidney disease
Diabetic kidney disease (DKD) is one of complications of diabetes mellitus with severe microvascular lesion and the most common cause of end-stage chronic kidney disease (ESRD). Controlling serum glucose remains the primary approach to preventing and slowing the progression of DKD. Despite considera...
Autores principales: | Lin, Yongda, Yang, Qian, Wang, Jiali, Chen, Xiutian, Liu, Yiping, Zhou, Tianbiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366010/ https://www.ncbi.nlm.nih.gov/pubmed/35966088 http://dx.doi.org/10.3389/fendo.2022.962635 |
Ejemplares similares
-
Signaling Pathways of Podocyte Injury in Diabetic Kidney Disease and the Effect of Sodium-Glucose Cotransporter 2 Inhibitors
por: Chen, Xiutian, et al.
Publicado: (2022) -
Cardiovascular outcomes and safety of SGLT2 inhibitors in chronic kidney disease patients
por: Chen, Xiutian, et al.
Publicado: (2023) -
Mesenchymal stem cells: A new therapeutic tool for chronic kidney disease
por: Wang, Jiali, et al.
Publicado: (2022) -
Gut microbiota: a newly identified environmental factor in systemic lupus erythematosus
por: Yao, Kaijin, et al.
Publicado: (2023) -
An Overview of the Safety, Efficiency, and Signal Pathways of Stem Cell Therapy for Systemic Lupus Erythematosus
por: Yang, Qian, et al.
Publicado: (2021)